MFDS
- Marketing authorisation holder: FOREST LABS
- Status: likely_approved
🇰🇷 Betaprone in South Korea
Betaprone (PROPIOLACTONE) regulatory status in South Korea.
Marketing authorisation
Betaprone in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Other approved in South Korea
Frequently asked questions
Is Betaprone approved in South Korea?
Yes. MFDS has authorised it.
Who is the marketing authorisation holder for Betaprone in South Korea?
FOREST LABS holds the South Korean marketing authorisation.